GeneLink, Inc. (OTCPK: GNLK.Q)
Health Care · Biotechnology · US
$—
— today · — 1Y
GeneLink, Inc. (OTCPK: GNLK.Q) operates in the Biotechnology industry within the Health Care sector. The company is valued at $10.60K.
trading between 0.00 and 0.00.
Tweenvest scores GeneLink, Inc. across four factors: quality 10/100, value 56/100. Its strongest factor is value.
GNLK.Q price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $10.60K
- Revenue (TTM)
- $1.58M
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- -210.42
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 265.02M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| ObsEva SAOTCPK: OBSE.F | $11.72K | $0.00 | +9900.00% |
| MabCure, Inc.OTCPK: MBCI | $11.72K | $— | — |
| Trevena, Inc.OTCPK: TRVN | $11.51K | $0.01 | +7.14% |
| Syros Pharmaceuticals, Inc.OTCPK: SYRS | $10.73K | $0.00 | -96.67% |
| Navidea Biopharmaceuticals, Inc.OTCPK: NAVB.Q | $10.00K | $0.00 | +9900.00% |
| Bioasis Technologies Inc.OTCPK: BIOA.F | $7.94K | $0.00 | — |
| Theralink Technologies, Inc.OTCPK: THER | $6.15K | $— | — |
| FluoroPharma Medical, Inc.OTCPK: FPMI | $5.51K | $0.00 | — |
Figures last refreshed Oct 4, 2026.